Add-on Sacubitril/Valsartan Therapy Induces Left Ventricular Remodeling in Non-responders to Cardiac Resynchronization Therapy to a Similar Extent as in Heart Failure Patients Without Resynchronization

Abstract Introduction Non-responders to cardiac resynchronization therapy (CRT-NR) have poor prognosis. Sacubitril/valsartan (SV) treatment improved the outcome of patients with heart failure with reduced left ventricular (LV) ejection fraction (HFrEF) in randomized trials with no data on the specif...

Descrición completa

Detalles Bibliográficos

Principais autores:	Krisztina Mária Szabó, Anna Tóth, László Nagy, Vivien Rácz, Zsófia Pólik, Katalin Hodosi, Attila C. Nagy, Judit Barta, Attila Borbély, Zoltán Csanádi
Formato:	Artigo
Idioma:	Inglês
Publicado:	Adis, Springer Healthcare 2024-01-01
Series:	Cardiology and Therapy
Assuntos:	Heart failure with reduced ejection fraction Cardiac resynchronization therapy Sacubitril/valsartan NT-pro-B-type natriuretic peptide
Acceso en liña:	https://doi.org/10.1007/s40119-023-00346-1
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!